Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease

Randomized trials of pulmonary vasodilators in pulmonary hypertension due to left heart disease (Group 2) and lung disease (Group 3) have demonstrated potential for harm. Yet these therapies are commonly used in practice. Little is known of the effects of treatment outside of clinical trials. We aim...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pulm Circ
Autori principali: Gillmeyer, Kari R., Miller, Donald R., Glickman, Mark E., Qian, Shirley X., Klings, Elizabeth S., Maron, Bradley A., Hanlon, Joseph T., Rinne, Seppo T., Wiener, Renda S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2021
Soggetti:
Original Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8020250/
https://ncbi.nlm.nih.gov/pubmed/33868640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20458940211001714
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi